Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Working capital requirements
Funding the company's ongoing working capital needs to support its manufacturing and distribution operations.
Repayment or prepayment of borrowings
Repaying or prepaying certain outstanding borrowings availed by the company.
Capital expenditure for dry flowable plant
Setting up an in-house dry flowable (DF) formulation plant at Barwasni, Sonipat district, Haryana.
General corporate purposes
The balance of the fresh issue proceeds applied toward general corporate purposes.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Indogulf Cropsciences Limited is an Indian agrochemical manufacturer incorporated in 1993, engaged in producing crop protection chemicals, plant nutrients and biologicals. The company is one of the few Indian manufacturers of Spiromesifen technical at 96.5 percent purity since 2019, and one of the first indigenous producers of Pyrazosulfuron Ethyl technical at 97 percent purity, giving it a technical-grade manufacturing base that many formulators in the industry rely on. The company operates four production units across Nathupur in Haryana and Samba in Jammu and Kashmir, spanning roughly twenty acres, and distributes its products across 22 Indian states and 3 union territories as well as more than 34 countries internationally, having been recognised as a Two Star Export House. Its research capability is backed by a NABL-certified laboratory and six patents granted since FY19, supporting a pipeline of technical and formulation products beyond its core molecules. Ownership is held by the promoter group led by Om Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal and Arnav Aggarwal. The company has maintained relatively stable operating and net margins over recent fiscal years, and used its IPO proceeds primarily to fund working capital, reduce borrowings and expand manufacturing capacity through a new dry flowable plant.
The company allocated shares to a set of anchor investors ahead of the IPO opening, including Abakkus Asset Manager, Viney Growth Fund, Swyom India Alpha Fund and Sunrise Investment Trust, with Rajasthan Global Securities alone receiving about Rs 58 crore worth of shares at the issue price of Rs 111.
Source: RHP • Analysis provided for informational purposes
Last Updated: 13 July 2026, 5:30 AM
Niche technical-grade manufacturing
The company is among a small group of Indian producers of Pyrazosulfuron Ethyl at high purity, giving it a differentiated position versus pure formulators.
Established export franchise
Recognition as a Two Star Export House and a presence across more than 34 countries reflects a mature international distribution network.
Integrated, multi-site operations
Technical, formulation and fertiliser manufacturing spread across four facilities gives the company flexibility in production and reduces single-site risk.
Consistent financial performance
Operating and net profit margins have stayed relatively stable across recent fiscal years despite input cost swings common in the agrochemical industry.
R&D-backed product pipeline
A NABL-certified laboratory and six patents granted since FY19 support ongoing development of new technical and formulation products.
Regulatory dependence
Manufacturing and marketing agrochemicals requires multiple regulatory approvals, and delays or denials could affect product launches and revenue.
Raw material cost exposure
Profitability is sensitive to swings in the cost of key agrochemical raw materials, many of which are commodity-linked.
Working-capital intensive model
The business carries moderate debt levels to fund a working-capital heavy operating cycle, which can pressure margins if funding costs rise.
Indogulf Cropsciences Limited
501, Gopal Heights, Plot No - D-9, Netaji Subhash Place, Delhi, New Delhi, 110034
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Export-related risks
Currency fluctuations and the need to meet varying international regulatory standards add complexity and risk to the export business.
Quality control risk
Any lapse in quality control could lead to order cancellations, reputational damage or litigation from customers.